Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcumin as adjunct to standard treatment in endometrial carcinoma
2013-001737-40Phase 2Completed
- Sponsor
- UZ Leuven
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of curcumin in endometrial cancer (EC), sponsored by UZ Leuven. Primary endpoint: Effect on inflammatory mediators in blood. Started Jun 2013; status: completed.
02
Drugs
curcumin
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on 2013-001737-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001737-40.